Cor Vasa 2015, 57(6):674-676
Trombolytická léčba u pacientů se submasivní plicní embolií (plicní embolií s intermediárním rizikem). Studie PEITHO uveřejněna
- Klinika kardiologie, Institut klinické a experimentální medicíny, Praha
Published: December 1, 2015 Show citation
References
- A. Torbicki, A. Perrier, S. Konstantinides, et al., Guidelines of the European Society of Cardiology for the Diagnosis and Management of Acute Pulmonary Embolism, European Heart Journal 29 (2008) 2276-2315
Go to original source...
- S. Konstantinides, A. Geibel, G. Heusel, et al., for the MAnagement Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators (MAPPET-3). Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism, New England Journal of Medicine 347 (2002) 1143-1150.
Go to original source...
Go to PubMed...
- J. Widimský, Diagnostika a léčba akutní plicní embolie, Cor et Vasa 55 (2013) 643-654
Go to original source...
- G. Meyer, E. Vicaut, T. Danais, et al.; for the PEITHO Investigators, Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism, New England Journal of Medicine 370 (2014) 1402-1411.
Go to original source...
Go to PubMed...
- C.G. Elliot, Fibrinolysis of Pulmonary Emboli - Steer Closer to Scylla, New England Journal of Medicines 370 (2014) 1457-1458.
Go to original source...
Go to PubMed...
- P.W. Armstrong, A.H. Gershlick, P. Goldstein, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. New England Journal of Medicine 368 (2013) 1379-1387.
Go to original source...
Go to PubMed...